Table 1.
Datasets included in the GSEA study to identify different immune process activated in men vs. women.
| Cancer type | Dataset | N | Excluded cases | Men | Women | Platform |
|---|---|---|---|---|---|---|
| Colon cancer | GSE17538 | 238 | 6 adenomas | 122 | 110 | Affymetrix HG-U133 Plus 2 |
| GSE18088 | 53 | 26 | 27 | Affymetrix HG-U133 Plus 2 | ||
| Gastric cancer | GSE26899 | 108 | 12 GIST, 3 normal tissue | 73 | 20 | Illumina HumanHT-12 V3.0 |
| GSE26901 | 109 | 69 | 40 | Illumina HumanHT-12 V3.0 | ||
| Head and neck cancer | GSE6791 | 84 | 28 cervical tissue, 14 HN normal tissue | 29 | 11 | Affymetrix HG-U133 Plus 2 |
| GSE30784 | 229 | 17 dysplasia, 45 control | 120 | 47 | Affymetrix HG-U133 Plus 2 | |
| GSE78060 | 30 | 4 normal tissue | 18 | 8 | Affymetrix HG-U133 Plus 2 | |
| GSE34105 | 78 | 16 control | 34 | 28 | Illumina HumanHT-12 WG-DASL V4.0 R2 | |
| GSE65858 | 270 | 14 secondary tumors | 211 | 45 | Illumina HumanHT-12 V4.0 | |
| Liver cancer | GSE9843 | 91 | 10 unknown sex | 54 | 27 | Affymetrix HG-U133 Plus 2 |
| Melanoma | GSE15605 | 46 | 32 | 14 | Affymetrix HG-U133 Plus 2 | |
| Pancreas cancer | GSE106189 | 35 | 23 | 14 | Affymetrix HG-U133 Plus 2 | |
| Renal cancer | GSE11904 | 21 | 13 | 8 | Affymetrix HG-U133A 2 | |
| GSE36895 | 76 | 23 normal, 24 mouse | 17 | 12 | Affymetrix HG-U133 Plus 2 | |
| GSE40435 | 202 | 101 normal | 59 | 42 | Illumina HumanHT-12 V4.0 | |
| GSE73731 | 265 | 3 unknown sex | 160 | 102 | Affymetrix HG-U133 Plus 2 | |
| Thyroid cancer | GSE53157 | 27 | 3 normal | 8 | 16 | Affymetrix HG-U133 Plus 2 |
| GSE60542 | 92 | 34 normal, 23 lymph node metastasis | 16 | 19 | Affymetrix HG-U133 Plus 2 | |
| Total | 1084 | 590 | ||||